Integrating Immunotherapy with the Standard-of-Care for HPV-related Head and Neck Cancer in HIV Patients
Andrew G. Sikora, MD, PhD
Caroline Wiess Law Translational Research Scholar
Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery
Baylor College of Medicine, Houston, TX
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2016. All rights reserved.
Andrew Sikora is associate professor of Otolaryngology and Vice Chair for Research, Carolyn Wiess Law Research Scholar, and Co-Director of the Head and Neck Cancer Program at the Baylor College of Medicine in Houston, Texas. Dr. Sikora’s research interests include understanding and reversing mechanisms of tumor-mediated immunosuppression, and the immunobiology of HPV-related head and neck cancer. He is the principle investigator of observational and therapeutic clinical trials designed to understand the impact of standard-of-care therapies on anti-tumor immunity, and to test novel immune-based therapies in head and neck cancer. As a nationally-recognized expert in cancer immunotherapy and clinical research, Dr. Sikora is a member of the US National Cancer Institute (NCI) Head and Neck Cancer Steering Committee, the NRG Oncology cooperative group Head and Neck Cancer Core Committee, and frequently serves on US National Institutes of Health (NIH) grant review panels.
At the completion of this educational session, learners will:
- Understand the role(s) of immunotherapy in treatment of HPV/HIV co-infected patients with cancer.
- Appreciate the impacts of standard-of-care treatments on immune function and anti-tumor immunity.
- Be aware of several modern approaches to cancer immunotherapy, including vaccination against tumor-associated antigens and immune checkpoint blockade.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Merck & Co, and ViiV Healthcare.
To obtain CME credit for this PRN program, please visit the
PRN Video Channel at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.
